273 related articles for article (PubMed ID: 18025108)
1. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
Shi J; Hu Z; Pabon K; Scotto KW
Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
3. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.
Merdzhanova G; Edmond V; De Seranno S; Van den Broeck A; Corcos L; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.
Apostolatos H; Apostolatos A; Vickers T; Watson JE; Song S; Vale F; Cooper DR; Sanchez-Ramos J; Patel NA
J Biol Chem; 2010 Aug; 285(34):25987-95. PubMed ID: 20547768
[TBL] [Abstract][Full Text] [Related]
5. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
[TBL] [Abstract][Full Text] [Related]
6. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
[TBL] [Abstract][Full Text] [Related]
7. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
8. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
[TBL] [Abstract][Full Text] [Related]
9. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
Loh TJ; Choi N; Moon H; Jang HN; Liu Y; Zhou J; Zheng X; Shen H
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):363-373. PubMed ID: 28119102
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor SC35 promotes tau expression through stabilization of its mRNA.
Qian W; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
FEBS Lett; 2011 Mar; 585(6):875-80. PubMed ID: 21333649
[TBL] [Abstract][Full Text] [Related]
11. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S
Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic factors control the unproductive splicing of SC35 terminal intron.
Dreumont N; Hardy S; Behm-Ansmant I; Kister L; Branlant C; Stévenin J; Bourgeois CF
Nucleic Acids Res; 2010 Mar; 38(4):1353-66. PubMed ID: 19965769
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
15. Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene.
Sureau A; Soret J; Guyon C; Gaillard C; Dumon S; Keller M; Crisanti P; Perbal B
Nucleic Acids Res; 1997 Nov; 25(22):4513-22. PubMed ID: 9358160
[TBL] [Abstract][Full Text] [Related]
16. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
17. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA.
Meshorer E; Bryk B; Toiber D; Cohen J; Podoly E; Dori A; Soreq H
Mol Psychiatry; 2005 Nov; 10(11):985-97. PubMed ID: 16116489
[TBL] [Abstract][Full Text] [Related]
18. Several mRNAs with variable 3' untranslated regions and different stability encode the human PR264/SC35 splicing factor.
Sureau A; Perbal B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):932-6. PubMed ID: 8302870
[TBL] [Abstract][Full Text] [Related]
19. The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis.
Gabut M; Miné M; Marsac C; Brivet M; Tazi J; Soret J
Mol Cell Biol; 2005 Apr; 25(8):3286-94. PubMed ID: 15798212
[TBL] [Abstract][Full Text] [Related]
20. Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms.
Shi J; Pabon K; Scotto KW
J Biol Chem; 2015 Jun; 290(24):14986-5003. PubMed ID: 25818199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
